查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2045945

馬匹保健市場－全球產業規模、佔有率、趨勢、機會和預測：按產品、疾病、活動、分銷管道、地區和競爭格局分類，2021-2031年

Equine Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Activity, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球馬匹保健市場預計將從 2025 年的 36.9 億美元成長到 2031 年的 59.6 億美元，複合年成長率為 8.32%。

該獸醫專科專注於研發和提供專門用於預防和治療馬匹疾病和損傷的藥品、生技藥品、診斷試劑和醫療設備。市場成長的主要驅動力是競技馬術運動日益成長的經濟價值。這部分歸因於競技馬術運動中對高性能馬匹的嚴格身體管理，以及全球對動物福利標準的日益重視，這些都促使人們加大對預防醫學的投資。

市場概覽
預測期 2027-2031
市場規模：2025年 36.9億美元
市場規模：2031年 59.6億美元
複合年成長率：2026-2031年 8.32%
成長最快的細分市場 診斷
最大的市場 北美洲

然而，該行業面臨諸多挑戰，包括營運成本飆升和專業人才短缺。根據美國馬匹出版公司（American Horse Publications）2025年的一份報告，50.3%的馬主和管理者認為不斷上漲的馬匹護理成本是該行業最緊迫的問題，另有35.5%的人表示在獲取獸醫服務方面存在困難。這些經濟負擔和合格人員的短缺限制了馬主獲得必要醫療服務的成本效益和可近性，嚴重阻礙了市場擴張。

市場促進因素

市場成長的主要驅動力是全球馬術和賽馬產業的顯著擴張。這些行業本身就需要先進的獸醫護理來維持比賽馬匹的競技狀態。隨著場地障礙賽、馬場馬術和純種馬賽馬等項目獎勵的不斷提升，馬主們正大力投資於全面的預防保健計劃和復健服務，以延長其寶貴馬匹的競技生涯。英國馬術協會於2025年6月發布的《2024年國家狀況報告》印證了這一行業參與度的不斷提高。報告指出，協會會員數量增加了11.7%，這與對常規疫苗接種、營養支持和專業運動醫學的需求激增直接相關，而這些對於維持馬匹的競技狀態至關重要。

同時，馬獸醫診斷和治療技術的突破性進展，特別是新型生物製藥和再生醫學的整合，正在改變治療方案。這項創新得益於藥物研發的大量投資，標誌著產業從症狀管理向治療方案提供方向的顯著轉變。例如，勃林格殷格翰強調致力於開發下一代動物用藥品解決方案的堅定決心，並計劃在2025年4月大幅增加研發支出，達到62億歐元。這種對尖端創新的投入正在對主要市場參與者的財務表現產生積極影響。例如，碩騰公司公佈2024年第三季銷售額達24億美元，反映出其豐富的動物用藥品系列獲得了廣泛的市場認可。

市場挑戰

全球馬匹醫療保健市場的擴張受到多重壓力的嚴重限制：營運成本不斷上漲和合格專業人員嚴重短缺。獸醫短缺是主要的供給面瓶頸，阻礙了該行業充分滿足日益成長的專業醫療服務需求。獸醫醫院在維持充足的人員配置方面面臨巨大挑戰，導致現有員工的工作量難以承受。這加劇了人員離職率，並從根本上限制了他們能夠處理的病例數。

隨著獸醫專業人才的匱乏，服務成本必然上漲，非緊急治療的等待時間延長，馬主被迫減少對獸醫服務的依賴。這種情況直接限制了市場收入成長，因為可高效開展的醫療程序數量有限。執業獸醫英國發布的《2025年報告》清晰地徵兆了這種短缺狀況，該報告指出，37%的獸醫每週加班，較上年的20%顯著增加。這項數據凸顯了目前基礎設施面臨的巨大壓力，嚴重限制了市場擴大營運規模以滿足全球需求的能力。

市場趨勢

改變獸醫實踐的關鍵趨勢之一是將人工智慧 (AI) 應用於診斷。這可以自動分析影像並提高決策的準確性。這項技術進步直接有助於緩解行業面臨的嚴重勞動力短缺問題，因為它使獸醫能夠加快病例審查速度並最大限度地減少錯誤，這得益於機器學習演算法能夠識別肉眼通常忽略的細微病變。透過實施這些數位化解決方案，動物醫院可以在不相應增加員工的情況下顯著提高患者處理能力和診斷可靠性。例如，Vetel Diagnostics 公司在 2024 年 7 月報告稱，其專有的 AI 軟體可以分析馬匹 X 光片並以 99.8% 的準確率識別重要的形態學異常，這充分展現了這些系統在輔助獸醫專業知識方面的強大作用。

同時，穿戴式健康監測設備的普及正透過持續的生物特徵追蹤，將市場從被動治療模式轉變為預防性健康管理模式。諸如智慧馬具和步態感測器等物聯網技術能夠提供生命徵象的即時數據，從而在症狀惡化之前及早發現諸如腹痛和跛行等問題。此功能提供客觀的歷史數據，最佳化獸醫診療。這對於維護高價值動物的身體健康和運動表現至關重要。這項技術的快速普及也體現在用戶數量上；截至2024年4月，Arioneo的「EQUIMETRE Vet」互聯感測器平台在全球已被超過22,700名用戶採用，這表明市場對數據驅動的馬匹健康管理有著顯著的需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球馬匹保健市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類別（疫苗、藥品、飼料添加劑、診斷試劑、軟體及服務、其他）
    • 適應症（肌肉骨骼疾病、寄生蟲控制、內科、馬皰疹病毒、馬腦​​脊髓炎、馬流感、西尼羅河病毒、破傷風、其他）
    • 依活動類型（體育/比賽、休閒、其他）
    • 分銷管道（獸醫院/診所、電子商務、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美馬匹醫療保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲馬匹醫療保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區馬匹醫療保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲馬匹醫療保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲馬匹醫療保健市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球馬匹保健市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Zoetis Inc.
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Hallmarq Veterinary Imaging Ltd
  • Esaote SpA
  • Vetoquinol SA
  • IDEXX Laboratories, Inc.
  • Dechra Pharmaceuticals PLC
  • Arthrex Inc.
  • Heska Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17486

The Global Equine Healthcare Market is anticipated to expand from USD 3.69 billion in 2025 to USD 5.96 billion by 2031, demonstrating an 8.32% Compound Annual Growth Rate. This specialized segment of veterinary medicine focuses on developing and delivering pharmaceuticals, biologics, diagnostics, and medical devices specifically for the prevention and treatment of diseases and injuries in horses. Market growth is primarily fueled by the increasing economic value associated with competitive equestrian sports, which necessitates rigorous physical maintenance for high-performance animals, alongside a growing global dedication to animal welfare standards that encourages investment in preventative medical care.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.69 Billion
Market Size 2031USD 5.96 Billion
CAGR 2026-20318.32%
Fastest Growing SegmentDiagnostics
Largest MarketNorth America

However, the industry faces notable impediments, including escalating operational costs and a scarcity of skilled professionals. A 2025 report by American Horse Publications indicated that 50.3 percent of equine owners and managers considered the rising cost of horsekeeping as the most pressing industry issue, with an additional 35.5 percent reporting challenges in accessing veterinary services. These financial burdens and the shortage of qualified practitioners significantly hinder market expansion by restricting the affordability and availability of essential medical interventions for horse owners.

Market Driver

The primary driver for market growth is the significant expansion of the global equestrian sports and racing industry, which inherently demands advanced veterinary care to preserve the athletic condition of competition horses. With increasing economic incentives in disciplines like show jumping, dressage, and thoroughbred racing, owners are heavily investing in extensive preventative health programs and rehabilitation services to extend the competitive careers of their valuable equine assets. Evidence for this heightened industry engagement comes from British Equestrian's June 2025 'State of the Nation 2024' report, which noted an 11.7 percent increase in federation memberships, directly correlating to a surge in demand for routine vaccinations, nutritional support, and specialized sports medicine essential for maintaining competition-ready horses.

Concurrently, breakthroughs in equine veterinary diagnostics and therapeutic technologies are transforming treatment possibilities, especially with the integration of novel biologics and regenerative medicine. This innovation signifies a notable industry shift from managing symptoms to delivering curative solutions, propelled by substantial investments in pharmaceutical research and development. For instance, Boehringer Ingelheim significantly boosted its R&D spending to EUR 6.2 billion by April 2025, emphasizing a proactive approach to developing next-generation animal health solutions. This dedication to cutting-edge innovation is positively impacting the financial performance of major market players, as illustrated by Zoetis reporting $2.4 billion in third-quarter revenue in 2024, reflecting strong commercial adoption of its diverse animal health product range.

Market Challenge

The Global Equine Healthcare Market's expansion is significantly impeded by the combined pressures of increasing operational expenses and a critical shortage of qualified professionals. This scarcity of veterinary practitioners creates a substantial supply-side bottleneck, hindering the industry's capacity to adequately address the escalating demand for specialized medical services. Veterinary practices face immense challenges in maintaining sufficient staffing, leading to unsustainable workloads for existing personnel, which in turn exacerbates attrition rates and physically restricts the volume of cases that can be managed.

This reduced availability of veterinary expertise inevitably drives up service costs and prolongs wait times for non-emergency treatments, compelling horse owners to limit their veterinary engagements. Such a dynamic directly curtails market revenue growth by capping the potential volume of efficiently delivered medical interventions. A clear indication of this workforce strain is the 2025 report from the Society of Practising Veterinary Surgeons, showing that 37 percent of veterinarians worked out-of-hours shifts weekly, a significant rise from 20 percent the prior year. This statistic underscores the intense pressure on current infrastructure, severely limiting the market's ability to scale operations in response to global demand.

Market Trends

A significant trend reshaping clinical practices is the integration of Artificial Intelligence in diagnostics, which automates image analysis and improves the accuracy of decision-making. This technological advancement directly helps mitigate the industry's critical workforce shortage by enabling practitioners to accelerate case reviews and minimize errors, thanks to machine learning algorithms capable of identifying subtle pathologies often missed by the human eye. By adopting these digital solutions, veterinary clinics can substantially enhance patient throughput and diagnostic reliability without needing a proportional increase in staffing. For example, Vetel Diagnostics reported in July 2024 that its proprietary AI software can analyze equine radiographs and identify significant morphological deviations with 99.8 percent accuracy, showcasing the power of these systems to augment veterinary expertise.

Concurrently, the widespread adoption of wearable health monitoring devices is transforming the market from a reactive treatment model to one of proactive wellness management through continuous biometric tracking. These IoT-enabled technologies, including smart halters and gait sensors, deliver real-time data on vital signs, facilitating the early detection of conditions such as colic or lameness before they progress to critical stages. This capability optimizes veterinary visits by supplying objective historical data, which is crucial for preserving the physical integrity and performance of high-value animals. The swift uptake of this technology is evident in user adoption figures, with Arioneo's EQUIMETRE Vet connected sensor platform being adopted by over 22,700 users globally by April 2024, indicating a substantial demand for data-driven equine health oversight.

Key Market Players

  • Zoetis Inc.
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Hallmarq Veterinary Imaging Ltd
  • Esaote SpA
  • Vetoquinol SA
  • IDEXX Laboratories, Inc.
  • Dechra Pharmaceuticals PLC
  • Arthrex Inc.
  • Heska Corporation

Report Scope

In this report, the Global Equine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Healthcare Market, By Product

  • Vaccines
  • Pharmaceuticals
  • Medicinal Feed Additives
  • Diagnostics
  • Software & Services
  • Others

Equine Healthcare Market, By Indication

  • Musculoskeletal Disorders
  • Parasite Control
  • Internal Medicine
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Others

Equine Healthcare Market, By Activity

  • Sports/Racing
  • Recreation
  • Others

Equine Healthcare Market, By Distribution Channel

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Others

Equine Healthcare Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Healthcare Market.

Available Customizations:

Global Equine Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others)
    • 5.2.2. By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others)
    • 5.2.3. By Activity (Sports/Racing, Recreation, Others)
    • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Equine Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Indication
    • 6.2.3. By Activity
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Equine Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By Activity
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Equine Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By Activity
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Equine Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By Activity
        • 6.3.3.2.4. By Distribution Channel

7. Europe Equine Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Indication
    • 7.2.3. By Activity
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Equine Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By Activity
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. France Equine Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By Activity
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. United Kingdom Equine Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By Activity
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Equine Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By Activity
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Equine Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By Activity
        • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Equine Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By Activity
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Equine Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By Activity
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Equine Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By Activity
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Japan Equine Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By Activity
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. South Korea Equine Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By Activity
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Equine Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By Activity
        • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Equine Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Indication
    • 9.2.3. By Activity
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Equine Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By Activity
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. UAE Equine Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By Activity
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. South Africa Equine Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By Activity
        • 9.3.3.2.4. By Distribution Channel

10. South America Equine Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Indication
    • 10.2.3. By Activity
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Equine Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By Activity
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Colombia Equine Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By Activity
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. Argentina Equine Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By Activity
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Equine Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zoetis Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boehringer Ingelheim GmbH
  • 15.3. Merck & Co., Inc.
  • 15.4. Hallmarq Veterinary Imaging Ltd
  • 15.5. Esaote SpA
  • 15.6. Vetoquinol SA
  • 15.7. IDEXX Laboratories, Inc.
  • 15.8. Dechra Pharmaceuticals PLC
  • 15.9. Arthrex Inc.
  • 15.10. Heska Corporation

16. Strategic Recommendations

17. About Us & Disclaimer